Bod Australia Ltd (AU:BOD) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Bod Science Limited has announced a deferral of its Annual General Meeting and financial reporting obligations due to its external administration status. The company, which focuses on cannabis-based drug development, will rely on regulatory relief to delay these requirements for up to 24 months. Investors are advised to monitor the situation as BOD navigates this period of financial restructuring.
For further insights into AU:BOD stock, check out TipRanks’ Stock Analysis page.